All Indications for Glivec/Gleevec and Tasigna
1 clinical trials · Condition
◉ Watch All Indications for Glivec/Gleevec and Tasigna
| Record | Firm | Date |
|---|---|---|
| A Global Imatinib and Nilotinib Pregnancy Exposure Registry (NCT01289054) | Novartis Pharmaceuticals | 2011-01-01 |
Track All Indications for Glivec/Gleevec and Tasigna automatically
Every clearance here is in the API, with alerts when new ones post.